Hospitals in England hit by shortages of common drugs such as paracetamol
Source: Guardian Health ↗
Dozens of NHS trusts across England are grappling with shortages of three staple medicines—aspirin, the painkiller co‑codamol (a paracetamol‑codeine blend), and the blood‑pressure tablet ramipril—highlighting a growing fragility in the health service’s drug supply chain. Freedom‑of‑information requests by University College London global‑health expert Dr Rodolfo Catena revealed that, of the 184 trusts queried, 60 responded, with 26 of the 42 trusts reporting disruptions to aspirin supplies between December and March, 13 of 42 experiencing co‑codamol scarcities, and seven of 43 lacking sufficient ramipril. Nine trusts reported problems with two of the three drugs, while Kent Community Health NHS Trust ran short of all three, forcing some hospitals to go weeks without the medications patients rely on for pain relief, clot prevention and hypertension control.
The shortages stem from a convergence of trade disputes, global conflict and manufacturing hiccups that have eroded the resilience of generic‑drug supply chains, which were previously considered low‑risk. While past shortages mainly affected specialist medicines such as those for ADHD or epilepsy, the current wave involves inexpensive, high‑volume drugs, prompting concerns that NHS England’s risk rating—currently a “medium” score of 16 out of 25—underestimates the threat. Catena argues that the lack of mandatory reporting by NHS trusts, unlike drug manufacturers, hampers early warning and mitigation, a view echoed by the National Pharmacy Association’s analysis of the shift toward generic drug scarcities.
Responses from the health sector underscore both the immediate pressures and the broader policy implications. Frimley Health NHS Trust resorted to paying higher prices for ramipril to maintain supply, while 92 % of responding trusts admitted they had no contingency plans and 82 % had not reported the shortages to NHS England. The Society for Acute Medicine warned that such gaps strain clinical and pharmacy teams and risk delaying patient care, urging stronger supply‑chain resilience and timely communication. A Department of Health and Social Care spokesperson acknowledged the limited ramipril supply, citing “serious shortage protocols” and ongoing work with suppliers, and emphasized government investment in UK drug manufacturing as a long‑term safeguard against future disruptions.
⚡ Effects Interpreter
🌍World Economymedium impact
What this means for you
- ▶Investors abroad often reprice their bets when a story like this lands.
- ▶Multinational firms typically adjust their playbooks when stories like this break.
🏙️Local Economylow impact
What this means for you
- ▶Local suppliers who import goods could pass on any change in costs.
- ▶Your weekly shop might get a touch dearer, or cheaper, down the line.
🏦Rates & Bankslow impact
What this means for you
- ▶Your bank is unlikely to act on this alone, but it will be watching.
- ▶Mortgage offers may firm up or soften as the picture becomes clearer.
❤️Healthlow impact
What this means for you
- ▶Vulnerable groups may want extra reassurance from a trusted source.
- ▶Everyday routines rarely need to change much once the facts are clear.
💷Wealthlow impact
What this means for you
- ▶Private treatment costs, where relevant, may shift as demand changes.
- ▶A healthy household budget and a healthy body typically go hand in hand.
🏠Housingmedium impact
What this means for you
- ▶Housing supply and demand rarely turn on a single piece of news.
- ▶Estate agents usually say the market takes weeks to catch up with news.
🌍 Effects for your country
The U.S.'s central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The U.S.'s economy is growing at 2.3% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the U.S.'s own central bank rate closely. With the U.S.'s unemployment at 4.4%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the U.S. depends more on local healthcare capacity than the figures above.
The UK's central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The UK's economy is growing at 0.8% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UK's own central bank rate closely. With the UK's unemployment at 5.6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the UK depends more on local healthcare capacity than the figures above.
France's central bank rate currently stands at 2%, so a global rates move like this could feed through to local borrowing costs. France's economy is growing at 0.9% with inflation at 1.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track France's own central bank rate closely. With France's unemployment at 7.9%, personal-finance effects like this land on a labour market that is already under strain. Health-system effects are harder to localise from economic indicators alone — the real impact in France depends more on local healthcare capacity than the figures above.
Romania's central bank rate currently stands at 6.5%, so a global rates move like this could feed through to local borrowing costs. Romania's economy is growing at 0.7% with inflation at 7.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track Romania's own central bank rate closely. With Romania's unemployment at 6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in Romania depends more on local healthcare capacity than the figures above.
The UAE's central bank rate currently stands at 3.65%, so a global rates move like this could feed through to local borrowing costs. The UAE's economy is growing at 3.1% with inflation at 2.5%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UAE's own central bank rate closely. Health-system effects are harder to localise from economic indicators alone — the real impact in the UAE depends more on local healthcare capacity than the figures above.